Dissecting the treatment of colorectal cancer
6 ESCO credits
17.07.2025 - 18.07.2025
Rabat, Morocco
VISITING PROFESSORSHIP MEETING
Description
| Host Chair | Visiting Professor |
 |
 |
| Hind Mrabti | Sara De Dosso |
The European School of Oncology makes support available for Clinical Institutes by proposing a Visiting Professorship Meeting (VPM).
The Clinical Institute is a renowned centre of reference for clinical oncology whose medical team is interested in attending and actively participating in an internal educational meeting held in English.
The medical/clinical oncology team of the host institute is invited by the Host Chair and attendance is free of charge.
The Visiting Professor is a renowned expert in an oncology topic and can adequately focus on the tumour type and discipline.
Programme
17 July | ||
| 8:30 | Registration | |
| 9:00 | Welcome and introduction of the visiting professor Sara De Dosso, CH | |
| 9:00 | Registration | |
| 9:15 | Epidemiology of GI cancers in Morocco, current practices and challenges Hassan Errihani, MA | |
| 9:30 | Session 1: Localized Colon cancer | |
| 9:30 | What makes a good pathology report? Basma El Khannoussi, MA | |
| 9:50 | Current treatment of localized colon cancer Sara De Dosso, CH | |
| 10:20 | Is there a place for neoadjuvant therapy in localized tumours? Sara De Dosso, CH | |
| 10:40 | ctDNA in early stage: how do we play it? Saber Boutayeb, MA | |
| 10:10 | Coffee break | |
| 10:30 | Clinical cases presented by the medical team of the center | |
| 11:05 | Coffee break | |
| 11:20 | Closing remarks | |
| 11:25 | 2 clinical cases about colon cancer in the early setting | |
| 12:00 | Lunch | |
| 13:00 | Session 2: Metastatic colo-rectal cancer | |
| 13:00 | State of art of first- and second-line treatment Sara De Dosso, CH | |
| 13:30 | Maintenance therapy: why is it so important? Salma Najem, MA | |
| 13:45 | Oligometastatic disease: A continuum of care Salma Najem, MA | |
| 14:05 | Surgery of the liver: how and when? Amine Benkabbou, MA | |
| 14:25 | What’s new in the refractory setting Hind Mrabti, MA | |
| 14:45 | Coffee break | |
| 15:05 | Clinical case discussion | |
| 16:05 | Multidisciplinary tumour board discussion | |
18 July | ||
| 9:00 | Registration | |
| 9:15 | Session 3: Rectal cancer | |
| 9:15 | Localized rectal cancer: what options do we have today? Karima Nouni, MA | |
| 9:35 | Atypical oligometastatic situations: How to navigate systemic and local treatment | |
| 9:35 | The Surgical Perspective: When and How to Intervene? Amine Souadka, MA | |
| 9:50 | The Oncological Perspective: Optimizing Systemic Therapy in the total neoadjuvant treatment era Sara De Dosso, CH | |
| 10:10 | Coffee break | |
| 10:30 | 2 Clinical cases presented by the medical team of the center | |
| 11:20 | Closing remarks | |
Faculty
Amine Benkabbou, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Saber Boutayeb, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Basma El Khannoussi, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Hassan Errihani, Institut National d'Oncologie, Service d'Oncologie Médicale, Rabat, MA
Hind Mrabti, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Salma Najem, National institute of Oncology of Rabat, Medical Oncology Dpt., Rabat, MA
Karima Nouni, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Amine Souadka, National Cancer Institute, Medical Oncology Dept., Rabat, MA
Information
ORGANISING SECRETARIAT
Dolores Knupfer
European School of Oncology
Via Vincenzo Vela, 6
6500 Bellinzona, Switzerland
Tel: + 41 91 820 09 52
Email: dknupfer@eso.net